Schonfeld Strategic Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $11.7M | Buy |
|
|||||
|
2023
Q1 | $5M | Sell |
|
|||||
|
2022
Q4 | $9.98M | Sell |
|
|||||
|
2022
Q3 | $7.38M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.35M | Buy |
|
|||||
|
2020
Q1 | $1.05M | Sell |
|
|||||
|
2019
Q4 | $3.59M | Buy |
|
|||||
|
2019
Q3 | $385K | Sell |
|
|||||
|
2019
Q2 | $792K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $991K | Buy |
|
|||||
|
2017
Q3 | $778K | Buy |
|